Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system

被引：2
|
作者：
Vabre, Clementine [1 ,2 ]
Zelmat, Yoann [3 ]
Gauthier, Martin [4 ,5 ]
Pajiep, Marie [3 ]
Conte, Cecile [3 ]
Lapeyre-Mestre, Maryse [2 ,3 ]
Dray-Spira, Rosemary [1 ]
Zureik, Mahmoud [1 ]
Despas, Fabien [2 ,3 ,6 ]
机构：
[1] French Natl Agcy Safety Med & Hlth Prod & French, EPI PHARE Sci Interest Grp Epidemiol Hlth Prod, Paris, France
[2] Univ Paul Sabatier Toulouse, Toulouse Univ Hosp, INSERM, Equipe PEPS,CIC 1436, Toulouse, France
[3] Toulouse Univ Hosp, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, Toulouse, France
[4] Toulouse Univ Hosp, Inst Univ Canc Oncopole, Dept Hematol, Toulouse, France
[5] Cahors Hosp, Dept Hematol, Cahors, France
[6] Univ Toulouse III, Inst Malad Metabol & Cardiovasc I2MC, UMR1297, INSERM DR Midi Pyrenees Limousin, Toulouse, France
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 08期
关键词：
D O I：
10.1002/ajh.26621
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E307 / E309
页数：3
相关论文
共 37 条
  • [21] Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System
    Penso, Laetitia
    Bergqvist, Christina
    Meyer, Antoine
    Herlemont, Philippe
    Weill, Alain
    Zureik, Mahmoud
    Dray-Spira, Rosemary
    Sbidian, Emilie
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (02) : 244 - 252
  • [22] Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study
    Ostgard, Lene Sofie Granfeldt
    Norgaard, Mette
    Medeiros, Bruno C.
    Friis, Lone Smidstrup
    Schoellkopf, Claudia
    Severinsen, Marianne Tang
    Marcher, Claus Werenberg
    Norgaard, Jan Maxwell
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) : 3678 - +
  • [23] Treatment outcomes in a population-based, 'real-world' cohort of patients with chronic myeloid leukemia (CML). EVIREPRO data base analysis
    Pintos, Luis
    Catalan, Marta
    Sanabria, Alba
    Kruss, Mariana
    Bunzel, Susana
    Gatto, Paola
    Santini, Fernando
    Cinara, Luis
    Pintos, Noemi
    Lopez, Anabella
    Sgromo, Mariana
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S25 - S26
  • [24] Tyrosine Kinase Inhibitors Initiation, Cost Sharing, and Health Care Utilization in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study
    Phuar, Hsiao Ling
    Begley, Charles E.
    Chan, Wenyaw
    Krause, Trudy Millard
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (10): : 1140 - 1150
  • [25] Efficacy and Safety of Tyrosine Kinase Inhibitors for Treatment of Newly Diagnosed Chronic Myeloid Leukemia: Results Using Data Obtained with the New Target System from the Japanese Registry
    Takahashi, Naoto
    Kizaki, Masahiro
    Miura, Masatomo
    Kawaguchi, Tatsuya
    Suzuki, Ritsuro
    Yamamoto, Kazuhito
    Ohnishi, Kazunori
    Matsumura, Itaru
    Naoe, Tomoki
    Akashi, Koichi
    BLOOD, 2018, 132
  • [26] Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in "Real-Life" Settings: A Population-Based Study Using a Nationwide Claim Database
    Benmerad, Meriem
    Chassetuillier, Jules
    Bouvier, Christophe
    Lecoq, Pierre-Louis
    Favier, Romain
    Trancart, Matthieu
    Hayette, Sandrine
    Bollard, Julien
    Lajoinie, Audrey
    Nicolini, Franck E.
    BLOOD, 2023, 142
  • [27] Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia A Retrospective Claims-Based Study
    Phuar, Hsiao Ling
    Begley, Charles E.
    Chan, Wenyaw
    Krause, Trudy Millard
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (07): : 517 - 525
  • [28] Long-Term Survival of Patients with Chronic Phase Chronic Myeloid Leukemia Who Received Autologous Stem Cell Transplantation and Further Exposed to Tyrosine Kinase Inhibitors. a Study on Behalf of the French Society of Blood and Marrow Transplantation and the French Group of CML
    Michallet, Mauricette
    Sobh, Mohamad
    Charbonnier, Aude
    Deconinck, Eric
    Dubruille, Viviane
    Coiteux, Valerie
    Delain, Martine
    Huguet, Francoise
    Rea, Delphine
    Bron, Dominique
    Raus, Nicole
    Delmer, Alain Jacques
    Lenain, Pascal
    Milpied, Noel
    Mahon, Francois-Xavier
    Nicolini, Franck Emmanuel
    Etienne, Gabriel
    BLOOD, 2017, 130
  • [29] Non-Optimal Treatment in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Tyrosine Kinase Inhibitors (TKI) in the United States: A Claims Data Analysis
    Kota, Vamsi
    Wei, David
    Yang, Daisy
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Guerin, Annie
    Jadhav, Kejal
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S365 - S366
  • [30] DO EDUCATION AND INCOME AFFECT TREATMENT AND OUTCOME IN ACUTE MYELOID LEUKEMIA IN A TAX-SUPPORTED HEALTH CARE SYSTEM? A DANISH NATIONAL POPULATION-BASED COHORT STUDY
    Ostgard, L. S.
    Norgaard, M.
    Medeiros, B. C.
    Friis, L. S.
    Schollkopf, C.
    Severinsen, M.
    Marcher, C. W.
    Norgaard, J. M.
    HAEMATOLOGICA, 2017, 102 : 44 - 44
1234